Home Applications 217225 Application 217225
Type NDA
Sponsor ASTELLAS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 IZERVAY AVACINCAPTAD PEGOL SODIUM SOLUTION;INTRAVITREAL EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217225-001 IZERVAY AVACINCAPTAD PEGOL SODIUM EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217225-001 8236773 2026-11-11 U-3673 2023-08-31 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 N217225-001 12016875 2034-07-11 U-3673 2024-10-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7579456 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 9617546 2025-02-14 U-3673 Drug substance 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 b8a1b40f171c…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join IZERVAY AVACINCAPTAD PEGOL Astellas Pharma US, Inc. 1642fe6a-dc26-4d20-ae6e-654af744e3bd 2026-02-27 Warnings, Adverse reactions Exact identifier application applno (NDA): 217225 application number: NDA217225
Documents# Document, Submission type, Date table Document Submission type Date 85278 SUPPL 2026-03-06 85209 SUPPL 2026-03-06 81250 SUPPL 2025-02-14 81240 SUPPL 2025-02-13 75344 ORIG 2023-09-01 75019 ORIG 2023-08-08 75011 ORIG 2023-08-07